Svt medication
Pro Research Analysisby 
Searched over 200M research papers for "svt medication"
Medications for Supraventricular Tachycardia (SVT)
Introduction to SVT and Its Treatment
Supraventricular tachycardia (SVT) is a common cardiac arrhythmia that originates above the ventricles. It can cause rapid heart rates and requires effective management to prevent complications. Various medications are used to manage SVT, each with its own efficacy and safety profile.
Digoxin vs. Propranolol in Infants
A multicenter, randomized controlled trial compared the efficacy and safety of digoxin and propranolol in infants with SVT. The study found no significant difference in SVT recurrence between the two medications. SVT recurred in 19% of patients on digoxin and 31% on propranolol, with no serious adverse events reported for either drug .
Ivabradine for Refractory SVT in Children
Ivabradine, typically used for coronary artery disease and heart failure, has shown promise in treating refractory SVT in pediatric patients. A retrospective study indicated that ivabradine successfully reversed SVT to sinus rhythm in 66% of treatment-resistant cases, suggesting it as a potential option for children who do not respond to conventional therapies .
Propranolol vs. Diltiazem Post-Coronary Artery Bypass Grafting
In patients undergoing coronary artery bypass grafting, propranolol was found to be more effective than diltiazem in preventing postoperative SVT. The incidence of SVT was significantly lower in the propranolol group (7%) compared to the diltiazem group (35%), highlighting propranolol's efficacy in this setting .
Etripamil Nasal Spray for Paroxysmal SVT
Etripamil, a short-acting calcium-channel blocker administered via nasal spray, is under investigation for the rapid termination of paroxysmal SVT. Early phase clinical trials have demonstrated its potential as a convenient and effective treatment, offering a non-parenteral option for patients .
Combination Therapy in Neonates
A study on neonatal SVT management revealed that while some infants could be managed with monotherapy, a significant number required combination therapy. Propranolol was the most commonly used medication, followed by amiodarone. The study emphasized the importance of tailored combination therapy to prevent SVT recurrence in neonates .
Adenosine Administration Techniques
A pilot study compared two techniques for administering adenosine to terminate SVT: the double-syringe technique (DST) and the single-syringe technique (SST). Both methods were found to be effective, with no significant difference in termination rates or complication rates, suggesting that SST could be a viable alternative to DST .
Conclusion
The management of SVT involves a variety of pharmacological options, each with specific indications and efficacy profiles. Digoxin and propranolol are commonly used in infants, while ivabradine shows promise for refractory cases in children. Propranolol is effective post-surgery, and etripamil nasal spray offers a novel approach for paroxysmal SVT. Combination therapy is often necessary in neonates, and different adenosine administration techniques can be equally effective. Further research and clinical trials will continue to refine these treatment strategies.
Sources and full results
Most relevant research papers on this topic
DOI